Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 282

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 282
---
 holders of Series A Preferred Stock party thereto
(the “PIPE Registration Rights Agreement”), (iv) our failure to cure a conversion failure of failure to deliver shares of
the Common Stock under the Series A Warrants, Preferred Warrants, and all warrants issued in exchange therefor or replacement thereof
(the “Structuring Warrants”) or notice of our intention not to comply with a request for conversion of any Series A Preferred
Stock or a request for exercise of any Structuring Warrants, and (v) bankruptcy or insolvency of us.

July Alternate Conversion Event. On July 5, 2024, the resale registration statement on Form S-1, which included the shares of Common Stock underlying the conversion
of the Series A Preferred Stock and Series B Preferred Stock, was declared effective. On the effectiveness of this S-1, the conversion
price of the Preferred Stock reset to $1.00 per share. The Series A Certificate of Designations defines a number of conditions that trigger
an Alternate Conversion Right, such right extending from the onset of the condition to 20 trading days after the condition is cured.
Due to late registration, the period of Alternate Conversion Right was from July 5, 2024 to August 2, 2024. The Alternate Conversion
Right triggered by late registration resulted in a 25% premium added to the conversion amount. At the time of Alternate Conversion, the
Alternate Conversion Price is the lowest of (a) the Conversion Price and (b) the greater of (i) the floor price and (ii) 80% of the lowest
daily VWAP of the Common Stock during the five trading days immediately preceding the date of conversion notice submission. However,
because the floor price was greater than 80% of the five-day volume-weighted average price of a share of Common Stock, the conversion
amount was further increased by a multiplier resulting in the convertibility of the shares of Series A Preferred Stock into the number
of shares of Common Stock that would have been issuable if the Alternate Conversion Price had been equal to such lower volume weighted
average price.

Other Adjustments.
If 90 days or 180 days following the occurrence of the later of (x) the Stockholder Approval Date (as defined below) and (y) the earlier
of (a) the effective date of the registration statement to be filed pursuant to the PIPE Registration Rights Agreement and (b) the date
that the Series A Preferred Stock is eligible to be resold without restriction under Rule